AsiaTIDES: Oligonucleotide and Peptide® Research, Technology and Product Development
The Only Event in Japan with Comprehensive Coverage of Oligonucleotides and Peptides
February 26 - February 28,--> 2013 · Tokyo, Japan
Updated: February 5, 2013
Driven by Excellence, Guided by Experience. With over 15 years of oligonucleotide manufacture, more than 1000 sequences produced at scale, and industry leading experience in validation and commercial product requirements, Avecia is proud to continue our tradition of 'Experience and Reliability from the First Gram.' Avecia's commitment to the future of the oligonucleotide market is driven by innovative ideas and flexible solutions, designed to provide our customers with the best in service, quality, and technology. From pre-clinical stages to commercial launch, you can count on Nitto Denko Avecia.
Agilent's Nucleic Acid Solutions Division offers industry leading experience to efficiently advance your lead oligo candidates from clinic to market with a common goal of patient health and safety. With Agilent, you always have peace of mind by partnering with a company that has the financial resources, stability and vision required for long-term success. Contact us at: firstname.lastname@example.org and find out why the world's most revolutionary biotech companies and their Big Pharma partners are choosing Agilent Technologies to develop and commercialize their oligo APIs.
Established in 1981, ChemGenes, the industry leader in Oligonucleotide Reagent manufacturing, has consistently provided the highest quality Phosphoramidites and Solid Supports in the market. Our Massachusetts facility is setup for therapeutic grade phosphoramidites and DNA/RNA synthesis products for GMP grade oligonucleotide manufacturing. Currently, our bulk synthesis capacities are 150kg/base yearly for 2'-O-Methyl and DNA phosphoramidites and 60kg/base yearly for RNA phosphoramidites. Additionally, ChemGenes carries the widest variety of modified phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic Acid research. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.
Lonza offers the life sciences market a full range of bioresearch products, development services and manufacturing for active ingredients. For 30 years we have been helping companies increase product quality, improve production processes, navigate regulatory hurdles, lower costs, and get to market faster. From early development to in-market supply, our complete development services, industry-leading manufacturing processes, broad technology platform and lifecycle management experience can help take your product to the next level. For flexible, high-quality manufacturing, development services and products, we can help.
BioSpring is a company in the chemical and biotechnology sectors producing oligonucleotides for use in therapeutics and diagnostics as well as for research purposes. The company offers a broad range of manufacturing scales ranging from small mg amounts for research and development up to several kg for clinical trials.
GeneDesign offers contract manufacturing of various oligonucleotides including PEGylation and Peptide conjugation from screening use to hundreds gram under the control of GMP guideline with sterilized condition. We can contribute to your successful oligo therapeutics development. We also have launched new oligo-synthesizer based on well expertise for long RNA manufacturing.
Spotlight Presentation Sponsors
Networking Reception and Dinner Co-Sponsors
Refreshment Break Sponsor
Corporate Suite Sponsor
Copyright IBC Life Sciences, a part of Informa Life Sciences Group.Phone: 800.390.4078Email: email@example.com